iatroX logo
brainstormaskiatroXuk q-bankus q-bankknowledge centreblog
Knowledge Centre / Pemphigoid

Pemphigoid

Overview of bullous pemphigoid.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 21 October 2025
Dermatology

Clinical Guidelines

British Association of Dermatologists guidelines for the management of bullous pemphigoid
National
Bullous Pemphigoid Clinical Practice Guidelines (EADV, 2022)
National
Guideline on the Diagnosis and Treatment of Autoimmune bullous diseases
National
European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid
Local
Guidelines – ERN Skin: Mucous Membrane Pemphigoid guidelines – guidelines (S3) on diagnosis
Local
Mucous Membrane Pemphigoid Clinical Practice Guidelines (EADV, 2021)
Local
Updated S2 K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (EADV)
Local
Updated S2 K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (EADV)
Local

Recent iatroX Q&As

  • What are the key clinical features to consider when diagnosing bullous pemphigoid in an elderly patient?Updated: 8/16/2025
  • When should I refer a patient with bullous pemphigoid to a dermatologist for further management?Updated: 8/16/2025
askiatroX
privacytermshow it workscpdinsightsfaqabout
UKCA Mark

iatroX is a UKCA-marked, MHRA-registered medical device.

Download on the App StoreGet it on Google Play